Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals

Australian Veterinary Journal

Volumn 89, Issue SUPPL.1, 2011, Pages 137-139

  Minke, J M ^a   El Hage, C M ^b   Tazawa, P ^c   Homer, D ^a   Lemaitre, L ^a   Cozette, V ^a   Gilkerson, J R ^b   Kirkland, P D ^d  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Wyong Equine Clinic   (Australia)

^d NSW DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

Emergency animal disease; Equine influenza; Horses; Vaccination

Indexed keywords

INFLUENZA VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUSTRALIA; BLOOD; CANARYPOX VIRUS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIOLOGY; EVALUATION; GENETICS; HORSE; HORSE DISEASE; IMMUNOLOGY; INFLUENZA VIRUS A H3N8; METHODOLOGY; NEWBORN; ORTHOMYXOVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; VACCINATION; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; AUSTRALIA; CANARYPOX VIRUS; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; VACCINES, SYNTHETIC;

ANIMALIA; EQUIDAE;

EID: 79959787041     PISSN: 00050423     EISSN: 17510813     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2011.00767.x     Document Type: Article

References (7)

1. Kirkland PD, Davis RJ, Wong D etal. The first five days: field and laboratory investigations during the early stages of the equine influenza outbreak in Australia, 2007. Aust Vet J 2011;89(Suppl 1):6-10.
2. Perkins NR, Webster WR, Wright T, Denney I, Links I. Vaccination program in response to the 2007 equine influenza outbreak in Australia. Aust Vet J 2011;89(Suppl 1):126-134.
3. Edlund Toulemonde C, Daly J, Guigal PM etal. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec 2005;156:367-371.
4. Minke JM, Edlund Toulemonde C, Coupier H etal. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am J Vet Res 2007;68:213-219.
5. Wood M, Mumford J, Folkers C etal. Studies with an inactivated equine influenza vaccine. I. Serological responses of ponies to graded doses of vaccine. J Hyg 1983;90:371-384.
6. Read AJ, Finlaison DS, Gu X etal. Application of real-time PCR and ELISA assays for equine influenza virus to determine the duration of viral RNA shedding and onset of antibody response in naturally infected horses. Aust Vet J 2011;89(Suppl 1):42-43.
7. Mumford JA, Wood J. Establishing an acceptability threshold for equine influenza vaccines. Dev Biol Stand 1992;79:137-146.